[Sedative effect of the mixture felsol in the dyspnea of asthmatics & cardiac patients].
D000700:Analgesics; D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use*; D058633:Antipyretics; D001249:Asthma / Q000150:complications*; D002110:Caffeine / Q000627:therapeutic use*; D002301:Cardiac Glycosides / Q000627:therapeutic use*; D004417:Dyspnea / Q000209:etiology*; D006331:Heart Diseases / Q000150:complications*; D006801:Humans; D006993:Hypnotics and Sedatives; D029746:Lobelia / Q000627:therapeutic use*
D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D058633:Antipyretics; D002301:Cardiac Glycosides; D006993:Hypnotics and Sedatives; D002110:Caffeine
ANALGESICS AND ANTIPYRETICS/therapeutic use; ASTHMA/complications; CAFFEINE/therapeutic use; CARDIAC GLYCOSIDES/therapeutic use; DYSPNEA/etiology and pathogenesis; HEART DISEASES/complications; LOBELIA/therapeutic use
Effetto sedativo del composto felsol nella dispnea degli asmatici e del cardiopatici.